Orthopedic Implants Market to Witness an Outstanding Growth During 2019-2030 - Zimmer Biomet, Stryker, Smith & Nephew

Orthopedic implants are medical devices which are used to support or replace damaged joints or bones. These implants are fabricated using several materials, namely titanium, stainless steel, and other plastic materials. These implants play a vital role in addressing several musculoskeletal conditions, by restoring mobility and reducing pain. Moreover, these implants further assists in treating deformities, restore normal skeletal function and stabilizing body posture among others. The global market is driven by growing geriatric population, and increasing incidences of osteoarthritis, & osteoporosis worldwide.

Moreover, rising medical tourism and advancements in technology has been crucial in contributing to the growth of the global market. For instance, advent of 3D printing technology has gained immense popularity among medical device manufacturers for fabrication of patient-specific implants, prototypes and biodegradable implants among others. However, high costs associated with procedures involving utilization of orthopedic implants coupled with stringent government regulations is likely to restrain the market to a certain extent.

Major Key Players of the Orthopedic Implants Market are:
Zimmer Biomet, Stryker, Smith & Nephew, DePuy Synthes , NuVasive, Medtronic, DJO Global, Arthrex, Inc., Globus Medical and B. Braun Melsungen AG among others

Read More @ http://www.sbwire.com/press-releases/orthopedic-implants-market-to-witness-an-outstanding-growth-during-2019-2030-zimmer-biomet-stryker-smith-nephew-1279608.htm 

Market Industry Reports (MIR) has published a new report titled "Orthopedic Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global orthopedic implants market is anticipated to grow at a CAGR of 6.2% from 2019 to 2030.

The continual growth of the orthopedic implants market can be attributed to several factors which have led to wide scale adoption of these products which are extensively used to improve body posture, treat deformities and other forms of musculoskeletal conditions among patients. Moreover, the growing geriatric population across the globe and rising medical tourism are anticipated to further contribute to the substantial growth of the global orthopedic implants market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. The University of Sheffield, has entered into a partnership with JRI Orthopaedics Ltd, a surgical instruments and orthopedic implants company, to improve the overall scope of technology and research in the field of orthopedics.

Read More @ http://www.sbwire.com/press-releases/orthopedic-implants-market-to-witness-an-outstanding-growth-during-2019-2030-zimmer-biomet-stryker-smith-nephew-1279608.htm 

Hemostatic Agents Market to Witness Robust Expansion by 2030 with Prominent Key Players: Baxter, Ethicon US, C. R. Bard, B. Braun

Hemostatic agents are used to control bleeding. A process that involves curbing the blood flow or bleeding through a blood vessel, or hemorrhage is called hemostasis. Hemostatic agents aid in hemostasis, by forming a clot at the injured area, thereby repairing the blood vessel. Primary hemostasis, secondary hemostasis, and fibrinolysis are some of the types of the hemostasis. Hemostatic agents are deployed to stem blood flow by promoting clotting, thereby enhancing the hemostasis through the coagulation process. These agents boost hemostasis by progressing primary hemostasis, increasing fibrin formation, or inhibiting fibrinolysis. Hemostatic agents play a pivotal role in curbing of bleeding or treating serious bleeds, thereby validating their usage in diverse therapeutic areas. They are not only used in hospital settings but also in military, clinics and home care settings.

Market Industry Reports (MIR) has published a new report titled "Global Hemostatic Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global hemostatic agents market was estimated to be over US$ 3 Bn in 2018. It is anticipated to grow at a CAGR of 6.1% from 2019 to 2030.

Major Key Players of the Hemostatic Agents Market are:
Baxter, Ethicon US, C. R. Bard, B. Braun Melsungen AG, Pfizer, Z-Medica, CryoLife, Integra LifeSciences, Advanced Medical Solutions Group plc. GELITA AG.

Read More @ http://www.sbwire.com/press-releases/hemostatic-agents-market-to-witness-robust-expansion-by-2030-with-prominent-key-players-baxter-ethicon-us-c-r-bard-b-braun-1279601.htm 

Surge in the number of surgical procedures conducted globally is expected to contribute towards the growth of the hemostatic agents market. The growth of the global market is further fueled by factors such as rising adoption of hemostats to restrain bleeding, rise in geriatric population requiring surgical procedures for various ailments, growing research and development activities worldwide. Owing to the growing demand for hemostatic agents that are quicker and cheaper, there is a remarkable opportunity for the key players in the hemostatic agents market to fill in this gap. Allergic reactions to human plasma or animal derived component in the hemostatic agents is anticipated to hamper the growth of this market.

There is a perpetual rise in the number of surgical procedures across the globe. Minimally invasive procedures are further driving the surgical volumes up. There has been a significant rise in health awareness among population and ample measures have introduced appropriate and effective treatments for diseases. Steady rise in geriatric population that requires medical attention and surgery to treat several aliments is fueling the demand for hemostatic agents, thus boosting the growth of the global hemostatic agents market. Hemostatic agents enable the surgeons to undertake technically challenging and complex surgical procedures, owing to the hemostat's ability to curb bleeding in a quicker and effective manner. Moreover, the hemostatic agents can be used across diverse medical applications, hence the surge in surgical procedures is expected to propel the growth of this market.

Read More @ http://www.sbwire.com/press-releases/hemostatic-agents-market-to-witness-robust-expansion-by-2030-with-prominent-key-players-baxter-ethicon-us-c-r-bard-b-braun-1279601.htm 

Diagnostic Imaging Services Market to Witness Growth Acceleration During 2019-2030 - RadNet, MedQuest Associates, Sonic Healthcare

Diagnostic imaging is a field of medicine that uses non-invasive imaging to diagnose a patient by various imaging procedures. These services include different types of technologies, techniques, and equipment's that are used to monitor, diagnose, screen, and treat medical conditions and deliver appropriate medical interventions. Diagnostic imaging has improved the ability of doctor's to treat, diagnose, and detect an injury or disease precisely at an initial stage. Additionally, diagnostic imaging services are can be used to provide relevant information associated with a targeted area of the body that needs to be treated or studied. Sometime the equipment used can involve low doses of radiation to create highly detailed images of an area. Diagnostic imaging services are used to identify a wide range of problems. Furthermore, to identifying problems, physicians can use diagnostic imaging to observe how your body is responding to an existing treatment. Diagnostic imaging also enables the doctors to make a rapid and accurate assessment of a patient's condition, empowering them with data that enables them to dispense the right treatment, which can then be delivered swiftly and effectively.

Market Industry Reports (MIR) has published a new report titled "Global Diagnostic Imaging Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global diagnostic imaging services market is estimated to reflect a CAGR of 7.9% in the forecast period.

Major Key Players of the Diagnostic Imaging Services Market are:
RadNet, MedQuest Associates, Center for Diagnostic Imaging (CDI), Sonic Healthcare, Concord Medical Services Holdings Limited, Alliance Medical, Simon Med/Dignity Health, Touchstone Imaging, Consensys Imaging Service, Inc., and InHealth Group, among others.

Read More @ http://www.sbwire.com/press-releases/diagnostic-imaging-services-market-to-witness-growth-acceleration-during-2019-2030-radnet-medquest-associates-sonic-healthcare-1279598.htm 

Increase in the incidence of chronic diseases, rising geriatric population, and growing prevalence of patient population that requires diagnostic imaging has resulted in diagnostic imaging services becoming a mainstay in the in the diagnosis of various chronic conditions including cancer, neurological and cardiovascular diseases. Technological advancements to enhance the quality of images and reduce the risk associated with using these equipment, especially X-ray based devices, and development of cost-effective imaging technologies have led to wider acceptance of diagnostic imaging procedures among healthcare providers. Increase in the accuracy and precision of diagnostic imaging has further boosted the growth of this market.

The advent of innovative diagnostic imaging technology such as 4D and 5D ultrasound medical devices, 7T MRI equipment, innovations in digital X-ray technologies and high-slice CT scanners are factors that are expected to be pivotal in the growth of the diagnostic imaging market. The market is estimated to be further fueled by factors such as evolution of diagnostic imaging techniques with lowered doses of ionizing radiation, thereby decreasing the harmful effects of radiation on patients as well as technicians and innovation of hybrid imaging systems.

Read More @ http://www.sbwire.com/press-releases/diagnostic-imaging-services-market-to-witness-growth-acceleration-during-2019-2030-radnet-medquest-associates-sonic-healthcare-1279598.htm 

Polyurethane Foams Market to Register Unwavering Growth During to 2030 - Huntsman Corporation, Covestro AG, the Dow Chemical Company, BASF

The global polyurethane foam market was valued at over US$ 50.0 Bn in 2018 and is anticipated to grow at a CAGR of 8.2% from 2019 to 2030. Polyurethane foams (PUFs) are the most vital class of polymeric foams. It accounts for more than 65% of the global polyurethane consumption. High demand of polyurethane foams from the construction and bedding & furniture industry is the major factor driving the market growth. Moreover, rising demand from automotive and electronic industries is bolstering the growth of the market. However, fluctuating prices of raw materials and stringent government regulations are the factors curbing the market growth.

Most of the polyols used in the manufacturing of polyurethane foams are petroleum derivatives. Owing to increasing environmental concerns and scarcity of petroleum in the future is forcing the manufacturers to use renewable and bio-based raw materials. Thus, renewable polyols is the obvious alternative for petroleum derived polyols. Companies such as BASF SE, Dow Chemical, Shell Chemicals Ltd and Bayer Material Science have already started the commercialization of bio-based polyols. Companies are continuously taking R & D activities to produce polyols from renewable sources such as vegetable oils and biomass residues.

Major Key Players of the Polyurethane Foams Market are:
Huntsman Corporation, Covestro AG, The Dow Chemical Company, BASF SE, Trelleborg AB and Recticel NV. Some of the other players present in this market are Chemtura Corporation, Sekisui Chemical Co. Ltd, Rogers Corporation and Fxi-Foamex Innovations among others.

Read More @ http://www.sbwire.com/press-releases/polyurethane-foams-market-to-register-unwavering-growth-during-to-2030-huntsman-corporation-covestro-ag-the-dow-chemical-company-basf-1279563.htm 

Polyurethane foams market is witnessing growth owing to rising demand from various end use industries. Polyurethane foams due to their low density, thermal conductivity and mechanical properties make them an excellent insulators and comfort materials. Therefore, it is widely used in broad range of end-use industries. Construction, bedding & furniture, electronics, footwear, packaging and automotive industries are the major consumers of polyurethane foams. Thus, rise in these industries will subsequently spur the adoption of polyurethane foams in numerous applications which in turn will drive the market growth.

Major Types of Polyurethane Foams Market covered are:
Flexible Foams
Rigid Foams

Major Applications of Polyurethane Foams Market covered are:
Building & Construction
Bedding & Furniture
Electronics
Automotive
Packaging & Others

Read More @ http://www.sbwire.com/press-releases/polyurethane-foams-market-to-register-unwavering-growth-during-to-2030-huntsman-corporation-covestro-ag-the-dow-chemical-company-basf-1279563.htm 

Carbon Black Market Detailed Insights on Upcoming Trends 2019-2030 - Birla Carbon, Orion Engineered Carbons, China Synthetic Rubber

Carbon black is pure elemental carbon in the form of colloidal particles. Carbon black is manufactured by four different process such as furnace black process, fabrication of gas blacks, acetylene black process and lampblack process. Furnace black process is the most widely used process. Carbon black is used in various materials to enhance the electrical, optical and physical properties of the final product. It is widely used in manufacturing of rubber products as reinforcement and performance additives.

Market Industry Reports (MIR) has published a new report titled "Carbon Black Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global carbon black market was valued at over US$ 14.0 Mn in 2018 and is anticipated to grow at a CAGR of 6.7% from 2019 to 2030. The market is driven by rising demand of tires owing to high demand from the automotive industry. Furthermore, rising demand from construction industry is another factor driving the market growth. Asia Pacific region offers huge market potential.

Major Key Players of the Carbon Black Market are:
Birla Carbon, Orion Engineered Carbons, Jiangxi Black Cat Carbon Black Co. Ltd. and Cabot Corporation, Phillips Carbon Black Ltd, China Synthetic Rubber Corporation, Mitsubishi Chemical Corporation, and OMSK Carbon Group among others.

Read More @ http://www.sbwire.com/press-releases/carbon-black-market-detailed-insights-on-upcoming-trends-2019-2030-birla-carbon-orion-engineered-carbons-china-synthetic-rubber-1279339.htm 

Rise in production of tires is the major factor driving the market growth. The tire market is witnessing growth owing to growing automotive industry. Carbon black is use widely as reinforcement additive in tire manufacturing. It helps to enhance the tear-strength, resilience and conductivity and other physical properties of the product. Carbon black is use in tire components such as sidewalls, inner liners and treads. Worldwide, the automotive industry is recovering from the economic crisis. As the automotive industry is witnessing growth, the demand for tire is growing which in turn is driving the market for black carbon.

Major Applications of Carbon Black Market covered are:
Rubber
Plastics
Coatings
Printing Inks
Construction & Others

Read More @ http://www.sbwire.com/press-releases/carbon-black-market-detailed-insights-on-upcoming-trends-2019-2030-birla-carbon-orion-engineered-carbons-china-synthetic-rubber-1279339.htm 

Intraosseous Devices Market to Witness an Outstanding Growth During 2019-2030 - Teleflex Inc, PERSYS MEDICAL, Cook

During emergencies and life threatening traumatic injuries it is important to establish vascular access, in order to supply fluid replacement and to deliver medications. Hence vascular access is pivotal in emergency situations, such as cardiac arrest. In certain situations when peripheral access becomes non-viable due to peripheral vasoconstriction it is important to establish vascular access so that patient outcomes are not compromised. Intraosseous devices offer a rapid, safe, and convenient way to administer medications and fluids to patients through the bone marrow. The use of intraosseous devices to gain vascular access is a widely acknowledged procedure during cardiopulmonary resuscitation (CPR).

The European Resuscitation Council (ERC) and American Heart Association (AHA) recommend the usage of intraosseous access during CPR if there's no possibility to instantly achieve peripheral vein access. Most of the intraosseous devices are successfully placed within less than a minute from the time of opening the package to using the device to administer the medication. Correct placement is confirmed by flow of intravenous fluid or medication into the device without any extravasation of the medication around the insertion site. Increase in the instances of emergency situations has prompted the key players in this market to work towards launching intraosseous devices that are technologically advanced, user friendly, have value added features, there by spur the growth of this market.

Major Key Players of the Intraosseous Devices Market are:
Teleflex Incorporated, PERSYS MEDICAL, Cook, BD, and Biopsybell, among others.

Read More @ http://www.sbwire.com/press-releases/intraosseous-devices-market-to-witness-an-outstanding-growth-during-2019-2030-teleflex-inc-persys-medical-cook-1279338.htm 

Market Industry Reports (MIR) has published a new report titled "Global Intraosseous Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global Intraosseous Devices market was estimated to be over US$ 365 Mn in 2018. It is anticipated to grow at a CAGR of 5.0% from 2019 to 2030.

Rapid rise globally in number of trauma cases, cardiac arrest instances, ageing population, focus on research and development activities, chronic diseases that lead to emergency situations, and the general rise in public health awareness are factors that have boosted the Intraosseous device market. These factors also offer a promising opportunity to the key players in this market to provide solutions for easy, quick and effective modes of vascular access. Value added features proffered by the intraosseous devices are encouraging physicians globally for adopting intraosseous devices. Increase in the instances of emergency situations has prompted the key players in this market to work towards launching intraosseous devices that are technologically advanced, user friendly, have value added features. Increasing approvals by the regulatory bodies, mergers and acquisitions of key players, and a developing product pipeline are anticipated to augment the global intraosseous devices market.

Read More @ http://www.sbwire.com/press-releases/intraosseous-devices-market-to-witness-an-outstanding-growth-during-2019-2030-teleflex-inc-persys-medical-cook-1279338.htm 

Monocyte Activation Test Market to Witness Huge Growth from 2019-2030 and Focusing on Top Key Players - Merck, Thermo Fisher Scientific, Becton

Monocyte activation test based on the reaction of human monocytes, now allows predicting the human response to all pyrogens (i.e. endotoxin and non-endotoxin) in vitro. The MAT can be used as alternative to animal-based pyrogen testing. The MAT is used to detect or quantify substances that activate human monocytes or monocyte cells to release endogenous mediators which have a role in the human fever response. The MAT offers significant advantages over animal-based pyrogen testing: based on the human fever response, it provides a more relevant prediction of pyrogenic activity than the rabbit pyrogen test (RPT), it can detect endotoxin and non-endotoxin pyrogens and is applicable to a greater variety of products than the RPT; moreover, it is more accurate as well as more cost and time-effective than various other pyrogen tests.

Market Industry Reports (MIR) has published a new report titled "Monocyte Activation Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." The global Monocyte Activation Test market was valued at over US$ 6.5 Mn. in 2018 and is anticipated to grow at a CAGR of 12.5% from 2019 to 2030.

Major Key Players of the Monocyte Activation Test Market are:
Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.

Read More @ http://www.sbwire.com/press-releases/monocyte-activation-test-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-merck-thermo-fisher-scientific-becton-1279336.htm 

The global monocyte activation test market is witnessing continuous advancements in test offerings and extensive growth in the product portfolio of major as well as local manufacturers. The growth of the global monocyte activation test market is attributed to increasing number of pharmaceutical and biotechnology industries globally, rising research and development, increased investments and surge in new drug approval activities. Additionally, a proposed ban on animal tests has resulted in reducing the use of the rabbit for pyrogen test. This is one of the significant factors that is driving the growth of monocyte activation tests globally. Increase in public and regulatory concerns about product safety further support the market growth.

Animals are used to test both the safety and efficacy of therapeutic drugs, cosmetics, household products, and chemicals. Fortunately there are developing numbers of effective non-animal alternatives that can replace the use of animals in pyrogen testing. Moreover, many countries have regulatory requirements that stipulate a ban on animal based pyrogen testing. There have been major changes in the European Union in recent years. In the EU the use of animals for pyrogen testing of cosmetic products has been banned since 2009, the use of animals for the testing of cosmetic ingredients also has been banned since March 2013.

Major Types of Monocyte Activation Test Market covered are:
Monocyte Activation Test Kits
Reagents

Major Applications of Monocyte Activation Test Market covered are:
Medical Devices
Lipid Parenteral
Dialysis Liquids
Blood Products
Toxic/immune-modulatory Drugs

Read More @ http://www.sbwire.com/press-releases/monocyte-activation-test-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-merck-thermo-fisher-scientific-becton-1279336.htm 

Cosmetic Lasers Market Professional and in-Depth Industry Analysis 2019-2030 by Top Key Players – Cutera, Cynosure, Alma Lasers, SharpLight Technologies

Cosmetic laser devices are used for cosmetic or aesthetic treatment to improve the physical appearance of an individual. These treatment procedures work on the mechanism of selective photothermolysis, where light source emitting a definite wavelength is used to produce a thermal effect. The thermal effect leads to lysis of the cells, thereby causing the destruction of unwanted cells. This form of treatment is minimally invasive and bears several advantages over its conventional counterparts.

Market Industry Reports (MIR) has published a new report titled "Cosmetic Lasers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global cosmetic lasers market is estimated to be over US$ 1,500 Mn in 2018. It is anticipated to grow at a CAGR of 13.4% from 2019 to 2030.

Major Key Players of the Cosmetic Lasers Market are:
Cutera, Cynosure, Alma Lasers, SharpLight Technologies, Aerolase, Syneron Medical, Sciton, Solta Medical, Lumenis Ltd and El.En. S.P.Aamong others.

Read More @ http://www.sbwire.com/press-releases/cosmetic-lasers-market-professional-and-in-depth-industry-analysis-2019-2030-by-top-key-players-cutera-cynosure-alma-lasers-sharplight-technologies-1279334.htm 

The continual growth of the cosmetic lasers market can be attributed to several factors which have led to wide scale adoption of these products which are extensively used to improve physical appearance of patients. Moreover, the growing demand for cosmetic treatments and therapies across the globe is anticipated to further contribute to the substantial growth of the global cosmetic lasers market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. The Anglia Ruskin University, based in England, has entered into an agreement with Allergen Inc., a cosmetic lasers company, to develop educational program for practicing physicians in the Asia Pacific region on facial aesthetics.

Over the years, the emergence of medical tourism as a popular and profitable industry has played a vital role in contributing to the growth of the global cosmetic lasers industry. Several countries, namely India, Turkey, Thailand, Brazil and other developing countries have emerged as essential contributors to global medical tourism industry. Multiple factors have been responsible for attracting patients to tour worldwide for medical treatments. Cost effectiveness, availability of personalized and tailor-made services, better facilities, convenience, and advanced technologies have been vital in contributing to the medical travel facilities. In 2017, it was estimated that the total number of medical tourists across all countries was a staggering 14-16 million.

Read More @ http://www.sbwire.com/press-releases/cosmetic-lasers-market-professional-and-in-depth-industry-analysis-2019-2030-by-top-key-players-cutera-cynosure-alma-lasers-sharplight-technologies-1279334.htm 

Alzheimer's Drugs Market to Witness Growth Acceleration During 2019-2030 - AC Immune, F. Hoffmann-La Roche, DAIICHI SANKYO

Alzheimer's disease is a progressive brain disorder, in which the brain gradually degenerates resulting in loss of memory, brain dysfunction, and cellular loss. It most often occurs in people aged above 65–70 years. A person afflicted with Alzheimer's also has to encounter issues with reasoning or judgment, steady decline in the ability to perform routine tasks, difficulty in learning, disorientation and loss of language skills. All these changes have a deep impact on not only the patient who is afflicted by the disease but also the care givers of the patient. This ultimately results in loss of independence of the patients and eventually complete dependence on the care givers. There are no definite symptoms for this disease and the biological changes in the brain at times can occur even decades before the first symptoms appear, making early diagnosis very difficult. By the time the patient reaches the late stages of the disease, they people are often unable to even communicate and become entirely dependent on their care givers even for simple day-to-day tasks. The current lot of Alzheimer's medications cannot cure or stop the disease from progressing. However they delay the progression or they might aid in lessening the intensity of the symptoms.

Market Industry Reports (MIR) has published a new report titled "Global Alzheimers Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global Alzheimers Drugs market was estimated to be over US $ 3.5 Bn in 2018. It is anticipated to grow at a CAGR of 7.2% from 2019 to 2030.

Major Key Players of the Alzheimer's Drugs Market are:
AC Immune, F. Hoffmann-La Roche, DAIICHI SANKYO COMPANY, Eli Lilly and Company, H. Lundbeck A/S, Eisai Co., Avanir Pharmaceuticals, Inc., Novartis AG, Janssen Global Services, LLC, AbbVie Inc. among others.

Read More @ http://www.sbwire.com/press-releases/alzheimers-drugs-market-to-witness-growth-acceleration-during-2019-2030-ac-immune-f-hoffmann-la-roche-daiichi-sankyo-1279034.htm 

Growing prevalence rates of Alzheimers disease globally and rising geriatric population worldwide is anticipated to fuel the growth of Alzheimers drugs market. With the globally increasing ageing population, the number of patients suffering from Alzheimers disease is projected to grow during the forecast period. According to the World Health Organization (WHO) between the years 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. It is estimated that dementia affects 46.8 million people worldwide with an estimated cost of USD 818 billion. Alzheimers disease is the most common cause of dementia, with 9.9 million people newly diagnosed with dementia each year. Unfortunately there is no cure for Alzheimers, which has become one of the greatest public health challenges globally. These factors are expected fuel the Alzheimers Drugs Market in the forecast period. Current treatments focus on delaying the onset of the disease and on alleviating the symptoms, however they are unable to stop the disease from progressing as they do not alter or affect the underlying causes.

Read More @ http://www.sbwire.com/press-releases/alzheimers-drugs-market-to-witness-growth-acceleration-during-2019-2030-ac-immune-f-hoffmann-la-roche-daiichi-sankyo-1279034.htm 

Virus Filtration Market to Witness Huge Growth from 2019-2030 and Focusing on Top Key Players - Asahi Kasei, Merck KGaA, Sartorius

The threat of contamination of biological products, namely vaccines, bio therapeutics and biologics is a major source of concern for laboratories, pharmaceutical companies and other research & educational establishments. Such contaminations may arise as a result of chemical impurities, fungi, bacteria and viruses. The occurrence of viral contamination affects the raw materials, cell culture, bioreactors and several downstream processes. Therefore, practicing virus safety and virus filtration studies is extremely pivotal in the process of manufacturing as well as research studies.

Market Industry Reports (MIR) has published a new report titled "Virus Filtration Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global virus filtration market is estimated to be over US$ 1,200 Mn in 2017. It is anticipated to grow at a CAGR of 12.1% from 2019 to 2030. The continual increasing adoption of biopharmaceuticals, namely biologics and other biotherapeutics has presented a bright prospect for the growth of virus filtration market. Increasing funding for R&D has further led to wide scale adoption of these filtration products for clearance of virus.

Major Key Players of the Virus Filtration Market are:
Asahi Kasei, Merck KGaA, Sartorius AG, Thermo Fisher Scientific, General Electric, Charles River, PendoTECH, Danaher, Lonza and Medical Respiratory Devices among others

Read More @ http://www.sbwire.com/press-releases/virus-filtration-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-asahi-kasei-merck-kgaa-sartorius-1279033.htm

Increasing preference for biopharmaceuticals and other forms of biotherapeutics have been crucial in governing the extensive growth of the biotechnology and pharmaceutical industries. In India, the biopharmaceutical sector accounted for the highest share, approximately around 64% of the entire biotechnology industry. Similarly, in the year 2016, the Indian biotechnology industry witnessed a staggering YoY growth of 57.14%. Growing preference for biopharmaceuticals owing to benefits has been pivotal in complementing the growth of these industries. Growth of these industries is anticipated to substantially contribute to the growth of virus filtration market, as these products are extensively used in these industries to obtain contamination free products and laboratories.

Major Types of Virus Filtration Market covered are:
Kits & Reagents
Virus Filters & Filtration Systems and Services

Major Applications of Virus Filtration Market covered are:
Biological (Blood & Blood Products, Vaccines & Therapeutics, and Stem Cell Products)
Water Purification
Medical Devices, and Air Purification

Read More @ http://www.sbwire.com/press-releases/virus-filtration-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-asahi-kasei-merck-kgaa-sartorius-1279033.htm

Medical Device Contract Manufacturing Market Prospects Outlook 2019-2030 and Top Key Players - Flextronics, Benchmark Electronics, Jabil

The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product. Contract manufacturing organizations (CMOs) are selected based on the capabilities of service provided in low cost, high quality and in speculated time. With increasing need for medical devices in hospitals and meet growing demand of hospitals OEMs are collaborating with Medical device contract manufacturing organization to meet this growing need.

Market Industry Reports (MIR) has published a new report titled "Medical Device Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global medical device contract manufacturing market is estimated to be over US$ 48 Bn in 2017. It is anticipated to grow at a CAGR of 8.5% from 2019 to 2030.

Major Key Players of the Medical Device Contract Manufacturing Market are:
Flextronics International, Benchmark Electronics, Jabil Inc., Integer Holdings Corporation (Greatbatch), West Pharmaceutical Services, Inc., Tecomet, Inc., Nortech Systems, TE Connectivity (Creganna Medical), Forefront Medical Technologies, Nordson Corporation and other prominent players.

Read More @ http://www.sbwire.com/press-releases/medical-device-contract-manufacturing-market-prospects-outlook-2019-2030-and-top-key-players-flextronics-benchmark-electronics-jabil-1279022.htm 

The global medical device contract manufacturing market is driven by focus of market players in introducing new and innovative products, rising geriatric population, need for cost effective products, rising cost for hospitals and increasing demand for medical devices are some of the major factors driving the market. Moreover, Polymer Science and Engineering Department of the University Of Massachusetts (UMASS) are offering several programs to enhance medical device industry and help to generate skilled workers. However, high cost of medical devices and stringent government policy related to medical device manufacturing is likely to restrain the market to certain extent.

The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global medical device contract manufacturing market in the coming times. Since, growing age brings about several ailments associated with arthritis and joints replacement.

Read More @ http://www.sbwire.com/press-releases/medical-device-contract-manufacturing-market-prospects-outlook-2019-2030-and-top-key-players-flextronics-benchmark-electronics-jabil-1279022.htm 

3D Cell Culture Market to Witness Huge Growth from 2019-2030 and Focusing on Top Key Players - Corning, Thermo Fisher Scientific, Merck & Co

3D cell culture involves artificially growing biological cells in all three surrounding directions. In 3D cell culture, the cells are grown in in-vitro conditions which in turn mimics in-vivo conditions. Three dimensional cultures in most cases are grown in bioreactors or capsules, where the cells grow in the form of spheroids. Advent of new techniques, namely scaffold-free systems utilized for translational pathway development for tissue have been extremely crucial in incrementing the demand for 3D cell culture market in recent times. Moreover, increasing R&D investments & funding from both private and public sector in the field of cell-based research has played a significant role in increasing the demand for such products. However, lack of infrastructure for research in relation to 3D cell culture is anticipated to restrain the growth of the market to a certain extent.

Market Industry Reports (MIR) has published a new report titled "3D Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global 3D cell culture market is estimated to be over US$ 600.0 Bn in 2017. It is anticipated to grow at a CAGR of 19.8% from 2019 to 2030.

Major Key Players of the 3D Cell Culture Market are:
Corning, Thermo Fisher Scientific, Merck & Co., Lonza, 3D Biotek, InSphero, REPROCELL USA, Nano3D Biosciences, SYNTHECON, INCORPORATED and QGel SA, Lausanne, Switzerland.

Read More @ http://www.sbwire.com/press-releases/3d-cell-culture-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-corning-thermo-fisher-scientific-merck-co-1279016.htm 

Increasing R&D investments & funding from both private and public sector in the field of cell-based research has presented a bright prospect for the growth of 3D cell culture market. Introduction of innovative new techniques has further led to wide scale application of such techniques and application of 3D cell culture FOR artificially growing biological entities.

Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, life sciences, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques, ideas to obtain latest breakthroughs in the field of life sciences. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by governmental establishments as well as major market players and other research institutes. Increasing R&D investments and spending is anticipated to positively contribute to the growth of the global 3D cell culture market.

Read More @ http://www.sbwire.com/press-releases/3d-cell-culture-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-corning-thermo-fisher-scientific-merck-co-1279016.htm 

Disposable Syringes Market Exploring Future Growth 2019-2030 and Key Players - Smiths Medical, Star Syringe, B. Braun Medical

Disposable syringes are drug delivery devices that are used in injecting varying dose of drug into the body. The dosage volume is fixed depending on the mediation, thereby, allowing the exact amount of drug to be injected without the possibility of human errors. The global disposable syringes market is driven by technologically advanced products & introduction of new cost effective products in the market, and rise in number of diabetes and chronic diseases patients. Similarly, rising adoption of biologics is anticipated to further contribute to the global disposable syringes market in the coming times. However, high cost related to disposable syringes, and presences of other drug delivery techniques are few of the factors likely to restrain the market to a certain extent.

Market Industry Reports (MIR) has published a new report titled "Disposable Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global disposable syringes market is estimated to be over US$ 6.5 Bn in 2018. It is anticipated to grow at a CAGR of 5.1% from 2019 to 2030.

Major Key Players of the Disposable Syringes Market are:
Smiths Medical, Star Syringe Limited, B. Braun Medical Inc., Baxter, TERUMO CORPORATION, Retractable Technologies, BD, Gerresheimer AG, Fresenius Kabi AG, and UltiCare among others

Read More @ http://www.sbwire.com/press-releases/disposable-syringes-market-exploring-future-growth-2019-2030-and-key-players-smiths-medical-star-syringe-b-braun-medical-1279010.htm

Increasing adoption of disposable syringes can be attributed to rising awareness, disposable incomes, and implementation of advanced drug delivery technologies. Moreover, rising prevalence of chronic disorders is anticipated to contribute substantially to the growth of the global disposable syringes market between 2019 and 2030. Several organizations have entered into strategic collaborations with manufacturers for research and development of efficient drug delivery techniques. For instance, PharmaJet, the drug-delivery technology company collaborated with the organization, Path, for evaluation of several drug delivery techniques and subsequently develop programs for country level immunization. However, needle stick injuries are one of the major restraining factors affecting the growth of the market. Nurses in hospitals are most likely to suffer from needle stick injuries. According to a study conducted by Shiraz University of Medical Sciences (SUMS) Iran, most of the needle stick injuries are from Hollow-bore needles and most common among nurses.

Major Types of Disposable Syringes Market covered are:
Conventional Syringes
Safety Syringes (Retractable Safety Syringes, And Non-Retractable Safety Syringes)

Major Applications of Disposable Syringes Market covered are:
Immunization Injections
Therapeutic Injections

Read More @ http://www.sbwire.com/press-releases/disposable-syringes-market-exploring-future-growth-2019-2030-and-key-players-smiths-medical-star-syringe-b-braun-medical-1279010.htm

Hypopigmentation Disorders Treatment Market to Witness Growth Acceleration During 2019-2030 - ALLERGAN, SkinCeuticals, PIERRE FABRE

The global hypopigmentation disorder treatment market is anticipated to reach a CAGR over 5.6% during the forecast period. Hypopigmentation is a skin condition, where the skin looses the color or skin pigments due to decrease in melanin or melanocyte. The formation of pigmented skins may occur in patches or all over the body. Although, hypopigmentation may occur among people of all races, but the occurrence of such a condition is more noticeable among individuals with dark complexion. Market Industry Reports (MIR) has published a new report titled "Hypopigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global hypopigmentation disorders treatment market is anticipated to witness a substantial CAGR of 5.6% in the forecast period.

Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hypopigmentation disorders treatment market. Moreover, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo is anticipated to be the major driver of the global hypopigmentation disorders treatment market between 2019 and 2030.

Major Key Players of the Hypopigmentation Disorders Treatment Market are:
ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, RXi Pharmaceuticals, Obagi Cosmeceuticals, and Alvogen among others

Read More @ http://www.sbwire.com/press-releases/hypopigmentation-disorders-treatment-market-to-witness-growth-acceleration-during-2019-2030-allergan-skinceuticals-pierre-fabre-1279007.htm

According to the American Academy of Dermatology, vitiligo is considered to be among 24 skin diseases, which are widely prevalent among the population. Vitiligo is known to affect individuals from all ethnic background and genders equivalently. While, vitiligo can affect people from all ages, but the prevalence of the same is more prominent among individuals between the age 10 and 30 years. Moreover, in 2013, it was estimated that more than 150,000 Americans from all age groups underwent treatment for vitiligo. Rising incidences and prevalence of vitiligo is anticipated to further contribute to the growing demand of the global hypopigmentation disorders treatment market.

Major Types of Hypopigmentation Disorders Treatment Market covered are:
Topical Drugs
Chemical Peels
Laser Therapy, and Microdermabrasion

Major Applications of Hypopigmentation Disorders Treatment Market covered are:
Dermatology Centers
Aesthetic Clinics, and Hospitals

Read More @ http://www.sbwire.com/press-releases/hypopigmentation-disorders-treatment-market-to-witness-growth-acceleration-during-2019-2030-allergan-skinceuticals-pierre-fabre-1279007.htm

Hearing Aids Market Detailed Insights on Upcoming Trends 2019-2030 - Sonova, William Demant Holding, GN Store Nord

Hearing aids are devices which amplify sound and assist individuals suffering from hearing impairment. Few of the constituents of these devices include, a microphone, for picking up sound, an amplifying circuit for relaying the sound louder and a miniature speaker which delivers the amplified sound to the ear, and finally, a battery to power the electronic components. The global hearing aids market is driven by increasing incidences and prevalence of hearing loss, focus of market players in introducing new and innovative products and availability of rising geriatric population are some of the major factors driving the market. However, high cost of device is likely to restrain the market to certain extent.

Market Industry Reports (MIR) has published a new report titled "Hearing Aids Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global hearing aids market is estimated to be over US$ 6.5 Bn in 2017. It is anticipated to grow at a CAGR of 6.6% from 2019 to 2030.

Major Key Players of the Hearing Aids Market are:
Sonova, William Demant Holding A/S, GN Store Nord A/S, Cochlear, Sivantos Pte. Ltd., Starkey, WIDEX A/S, SeboTek Hearing Systems, Audina Hearing Instruments, Inc. and Horentek other prominent players.

Read More @ http://www.sbwire.com/press-releases/hearing-aids-market-detailed-insights-on-upcoming-trends-2019-2030-sonova-william-demant-holding-gn-store-nord-1279002.htm 

Increasing incidences and prevalence of hearing loss, rising geriatric population has led to focus of market players in introducing new and innovative products and availability of favorable government regulations are some of the growth factors in the hearing aids market. Moreover, various educational and research institutes, organizations and societies are working on treatments of hearing losses to make the entire treatment procedure affordable. For instance, China Southeast University Institute of Life Sciences announced collaboration for joint research project with Boehringer Ingelheim, a leading pharmaceutical company.

The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global hearing aids market in the coming times. Since, growing age brings about several ailments associated with hearing, namely hearing loss, and other hearing problems.

Read More @ http://www.sbwire.com/press-releases/hearing-aids-market-detailed-insights-on-upcoming-trends-2019-2030-sonova-william-demant-holding-gn-store-nord-1279002.htm 

Genome Editing/Genome Engineering Market to Witness an Outstanding Growth During 2019-2030 - Thermo Fisher Scientific, Lonza, Merck

Genome Editing/Genome Engineering technique are used for insertion, deletion or modify genome of a microorganism. Techniques like TALEN, CRISPR (clustered regularly interspaced palindromic repeat) and other technique are widely used in genome editing/engineering process. CRISPR-Cas9 technique is one of the most widely preferred technologies in genome editing. The global genome editing/genome engineering market is driven by technological advancements in the genomics, rising number of cancer patients, and increasing funding by government & private players in the genomics are major factors driving the market. However, ethical issue related to genome editing/genome engineering is likely to restrain the market to certain extent.

Market Industry Reports (MIR) has published a new report titled "Genome Editing/Genome Engeineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report the global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is anticipated to grow at a CAGR of 14.1% from 2019 to 2030.

Major Key Players of the Genome Editing/Genome Engineering Market are:
Thermo Fisher Scientific, Lonza, Merck, Horizon Discovery Group, Integrated DNA Technologies, New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.

Read More @ http://www.sbwire.com/press-releases/genome-editinggenome-engineering-market-to-witness-an-outstanding-growth-during-2019-2030-thermo-fisher-scientific-lonza-merck-1279000.htm

Strong product pipeline are anticipated to impact the industrial growth over the forecast period of 2019–2030. The novel products are designed to help in development of DNA targeting, with improved flexibility, specificity of nuclease, and the ease of Adeno-Associate Virus (AAV) packaging for delivery. Moreover, utilization of the technique through a number of methods such as disruption of viral DNA, correction in the toxic mutations, or the addition of therapeutic transgenes is projected to boost the adoption.

Application of the technology for cell line genetic editing or engineering in the form of gene therapy and stem cell therapy accounted for the considerable share and is estimated to register lucrative growth. Furthermore, use of the genome editing technology for the development of novel molecules which can be targeted for treating various diseases such as infectious diseases and hematological malignancies is likely to drive the adoption of the technology in the coming years.

Read More @ http://www.sbwire.com/press-releases/genome-editinggenome-engineering-market-to-witness-an-outstanding-growth-during-2019-2030-thermo-fisher-scientific-lonza-merck-1279000.htm

Advanced Wound Care Market Competitive Analysis 2019-2030 and Key Players - Smith & Nephew, B. Braun, ConvaTec

Advanced wound care products are widely used to treat more complex wounds that require wound hydration and promote healing. The products are used as moisture therapy and applied around the wound area. Also these products provide protection from bacterial infection and other foreign elements thus maintaining stable temperature around the wound, protection from infection, removal of dead tissues, assistance in oxygenation, and relieve in pain.

Market Industry Reports (MIR) has published a new report titled "Advanced Wound Care Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global advanced wound care market is estimated to be over US$ 8.5 Bn in 2017. It is anticipated to grow at a CAGR of 4.3% from 2019 to 2030.

Major Key Players of the Advanced Wound Care Market are:
Smith & Nephew, B. Braun, ConvaTec Group, Integra LifeSciences, 3M, Cardinal Health, Medtronic, MPM Medical, Paul HARTMANN, and MiMedx Group, among others.

Read More @ http://www.sbwire.com/press-releases/advanced-wound-care-market-competitive-analysis-2019-2030-and-key-players-smith-nephew-b-braun-convatec-1278368.htm 

Technological advancements in the sector of wound therapy, growing geriatric population and treatment coupled with increasing awareness among patients have been pivotal in dictating the growth of the advanced wound care market. Moreover, efficient treatment options for complex wounds, diabetes and associated chronic wounds and increasing expenditures on healthcare is anticipated to be the major drive the growth of the global advanced wound care market between 2019 and 2030.Furthermore, key players have extensively focused on collaborating with several educational and research institutes to amplify R&D activities and meet the overall demands of the healthcare industry. For instance, Smith and Nephew a global medical device company entered into collaboration with University of Hull, to create wound care research cluster and facilitate development of advanced R&D centers.

The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global advanced wound care market in the coming times. Since, the utilization of advanced wound care products for assisting treatment and facilitating faster recovery of wounds among aged population is enormously crucial.

Read More @ http://www.sbwire.com/press-releases/advanced-wound-care-market-competitive-analysis-2019-2030-and-key-players-smith-nephew-b-braun-convatec-1278368.htm